Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemia.
Venanzi A, Cardinali V, Perriello V, Albano F, Cimino G, Martino G, Marra A, Sportoletti P, Andresen V, Gjertsen BT, Sica S, Chiusolo P, Martelli MP, Tiacci E, Falini B. Venanzi A, et al. Among authors: andresen v. Am J Hematol. 2025 Jan;100(1):139-143. doi: 10.1002/ajh.27415. Epub 2024 Jun 22. Am J Hematol. 2025. PMID: 39158266 No abstract available.
The NPM1 mutant defines AML irrespective of blast count.
Falini B, Martelli MP, Brunetti L, Gjertsen BT, Andresen V. Falini B, et al. Among authors: andresen v. Am J Hematol. 2023 Jul;98(7):E187-E189. doi: 10.1002/ajh.26946. Epub 2023 Apr 29. Am J Hematol. 2023. PMID: 37119006 Free article. No abstract available.
Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutations.
Khan AA, James D, Andresen V, Atkey J, Bradbury R, Cargo C, Dillon R, Gjertsen BT, Goldstone AR, Leach R, Lock D, Narayanan M, Russell N, Verigou EA, Green S, Fielding AK, Falini B. Khan AA, et al. Among authors: andresen v. Am J Hematol. 2024 Oct;99(10):2018-2022. doi: 10.1002/ajh.27301. Epub 2024 Apr 3. Am J Hematol. 2024. PMID: 38567798 No abstract available.
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein.
Pianigiani G, Rocchio F, Peruzzi S, Andresen V, Bigerna B, Sorcini D, Capurro M, Gjertsen BT, Sportoletti P, Di Ianni M, Martelli MP, Brunetti L, Falini B. Pianigiani G, et al. Among authors: andresen v. Leukemia. 2022 Jul;36(7):1931-1934. doi: 10.1038/s41375-022-01593-2. Epub 2022 May 14. Leukemia. 2022. PMID: 35568767 Free PMC article. No abstract available.
Overlapping features of therapy-related and de novo NPM1-mutated AML.
Othman J, Meggendorfer M, Tiacci E, Thiede C, Schlenk R, Dillon R, Stasik S, Venanzi A, Bertoli S, Delabesse E, Dumas PY, Pigneux A, Bidet A, Gilkes AF, Thomas I, Voso MT, Rambaldi A, Brunetti L, Perriello VM, Andresen V, Gjertsen BT, Martelli MP, Récher C, Röllig C, Bornhäuser M, Serve H, Müller-Tidow C, Baldus CD, Haferlach T, Russell N, Falini B. Othman J, et al. Among authors: andresen v. Blood. 2023 Apr 13;141(15):1846-1857. doi: 10.1182/blood.2022018108. Blood. 2023. PMID: 36508705 Free article.
137 results